Nephrology and Hypertension

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


1635 publications

... | 2021 | 2020 | 2019 | 2018 | ...
 
Metabolische Abklärung von Nierensteinen [Metabolic investigation of stone formers]
Bonny O., Bosshard P., 2021/06. Therapeutische Umschau. Revue therapeutique, 78 (5) pp. 235-240. Peer-reviewed.
 
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.
Meylan S., Livio F., Foerster M., Genoud P.J., Marguet F., Wuerzner G., CHUV COVID Vaccination Center, 2021/06. Hypertension, 77 (6) pp. e56-e57. Peer-reviewed.
 
Uromodulin, Salt, and 24-Hour Blood Pressure in the General Population.
Ponte B., Pruijm M., Ackermann D., Olinger E., Youhanna S., Vogt B., Burnier M., Pechere-Bertschi A., Bochud M., Devuyst O., 2021/05/08. Clinical journal of the American Society of Nephrology, 16 (5) pp. 787-789. Peer-reviewed.
 
Blood pressure target in patients with hypertension and type-2 diabetes older than 65 years. Is <130/80 mmHg the right target or an excessive objective preventing from achieving the clinical goals we are aiming at?
Burnier M., Narkiewicz K., Oparil S., 2021/04. Blood pressure, 30 (2) pp. 79-81. Peer-reviewed.
Eosinophilia Due to Central Venous Catheter in Hemodialysis Patients.
Chapelet-Debout A., Coupel S., de Geyer d'Orth G., Gourraud-Vercel C., Lefrançois G., Parahy S., Deltombe C., Ville S., Fakhouri F., 2021/04. Kidney international reports, 6 (4) pp. 1189-1191. Peer-reviewed.
 
In memoriam: Jiří Widimský Sr. 1925-2020.
Kreutz R., Cífková R., Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., Mancia G., 2021/04. Blood pressure, 30 (2) pp. 140-142. Peer-reviewed.
 
Outcome of kidney transplantation from very senior donors in Switzerland - a national cohort study.
Kuhn C., Lang B.M., Lörcher S., Karolin A., Binet I., Beldi G., Golshayan D., Hadaya K., Mueller T.F., Schaub S. et al., 2021/04. Transplant international, 34 (4) pp. 689-699. Peer-reviewed.
 
Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS).
Bandiera C., Dotta-Celio J., Locatelli I., Nobre D., Wuerzner G., Pruijm M., Lamine F., Burnier M., Zanchi A., Schneider M.P., 2021/03/19. JMIR research protocols, 10 (3) pp. e25966. Peer-reviewed.
Effects of the Dual Endothelin Receptor Antagonist Aprocitentan on Body Weight and Fluid Homeostasis in Healthy Subjects on a High Sodium Diet.
Gueneau de Mussy P., Sidharta P.N., Wuerzner G., Maillard M.P., Guérard N., Iglarz M., Flamion B., Dingemanse J., Burnier M., 2021/03. Clinical pharmacology and therapeutics, 109 (3) pp. 746-753. Peer-reviewed.
Spectrum of Kidney Involvement in Patients with Myelodysplastic Syndromes.
Schwotzer N., Provot F., Ville S., Daniel L., Le Fur A., Kissling S., Jourde-Chiche N., Karras A., Moreau A., Augusto J.F. et al., 2021/03. Kidney international reports, 6 (3) pp. 746-754. Peer-reviewed.
Complément et rein [Complement system and kidney]
Halfon M., Pascual M., Sadallah S., Fakhouri F., 2021/02/24. Revue medicale suisse, 17 (727) pp. 383-388. Peer-reviewed.
Editorial: Hypertension in the Elderly.
Coca A., Burnier M., 2021/02/24. Frontiers in cardiovascular medicine, 8 p. 645580. Peer-reviewed.
Histoire d’eau : le tolvaptan dans tous ses états [Clinical use of tolvaptan: a 2021 review]
Bonny O., Martin P.Y., Stucker F., 2021/02/24. Revue medicale suisse, 17 (727) pp. 399-404. Peer-reviewed.
Inhibiteurs du SGLT2 dans les néphropathies diabétiques et non diabétiques [SGLT2 inhibitors in diabetic and non-diabetic nephropathies]
Scheen M., Zanchi A., Martin P.Y., De Seigneux S., 2021/02/24. Revue medicale suisse, 17 (727) pp. 378-382. Peer-reviewed.
Le prix de l’innovation en néphrologie []
Fakhouri F., Martin P.Y., 2021/02/24. Revue medicale suisse, 17 (727) p. 371. Peer-reviewed.
 
Sodium intake and progression of chronic kidney disease-has the time finally come to do the impossible: a prospective randomized controlled trial?
Burnier M., 2021/02/20. Nephrology, dialysis, transplantation, 36 (3) pp. 381-384. Peer-reviewed.
Gene regulation contributes to explain the impact of early life socioeconomic disadvantage on adult inflammatory levels in two cohort studies.
Carmeli C., Kutalik Z., Mishra P.P., Porcu E., Delpierre C., Delaneau O., Kelly-Irving M., Bochud M., Dhayat N.A., Ponte B. et al., 2021/02/04. Scientific reports, 11 (1) p. 3100. Peer-reviewed.
 
CME: Hypertonie und die COVID-19-Pandemie: Was in der medizinischen Praxis zu beachten ist [CME: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]
Wuerzner G., Waeber B., 2021/02. Praxis, 110 (2) pp. 60-64. Peer-reviewed.
 
CME: L’hypertension artérielle et la pandémie COVID-19: Ce qu’il faut retenir en pratique médicale [CME: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]
Wuerzner G., Waeber B., 2021/02. Praxis, 110 (2) pp. 1-5. Peer-reviewed.
 
Impact of obesity with or without hypertension on systemic haemodynamic and renal responses to lower body negative pressure.
Vakilzadeh N., Petrovic D., Maillard M., Favre L., Grouzmann E., Wuerzner G., 2021/02. Blood pressure, 30 (1) pp. 67-74. Peer-reviewed.
 
In Memoriam: Jiří Widimský Sr. 1925-2020.
Kreutz R., Cífková R., Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., Mancia G., 2021/02/01. Journal of hypertension, 39 (2) pp. 386-388. Peer-reviewed.
 
Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2021/02. Blood pressure, 30 (1) pp. 1-3. Peer-reviewed.
Regulation of plasma volume in male lowlanders during 4 days of exposure to hypobaric hypoxia equivalent to 3500 m altitude.
Schlittler M., Gatterer H., Turner R., Regli I.B., Woyke S., Strapazzon G., Rasmussen P., Kob M., Mueller T., Goetze J.P. et al., 2021/02. The Journal of physiology, 599 (4) pp. 1083-1096. Peer-reviewed.
 
Urine and stone analysis for the investigation of the renal stone former: a consensus conference.
Williams J.C., Gambaro G., Rodgers A., Asplin J., Bonny O., Costa-Bauzá A., Ferraro P.M., Fogazzi G., Fuster D.G., Goldfarb D.S. et al., 2021/02. Urolithiasis, 49 (1) pp. 1-16. Peer-reviewed.
Hypertension artérielle [Hypertension: novelties 2020]
Berney M., Wuerzner G., Ponte B., Pechère-Bertschi A., 2021/01/27. Revue medicale suisse, 17 (723) pp. 192-195. Peer-reviewed.
Atypical HUS relapse triggered by COVID-19.
Ville S., Le Bot S., Chapelet-Debout A., Blancho G., Fremeaux-Bacchi V., Deltombe C., Fakhouri F., 2021/01. Kidney international, 99 (1) pp. 267-268. Peer-reviewed.
Bariatric Surgery Induces a Differential Effect on Plasma Aldosterone in Comparison to Dietary Advice Alone.
Berney M., Vakilzadeh N., Maillard M., Faouzi M., Grouzmann E., Bonny O., Favre L., Wuerzner G., 2021. Frontiers in endocrinology, 12 p. 745045. Peer-reviewed.
Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy.
Guzzo G., Sadallah S., Fodstad H., Venetz J.P., Rotman S., Teta D., Gauthier T., Pantaleo G., Superti-Furga A., Pascual M., 2021. Frontiers in genetics, 12 p. 529236. Peer-reviewed.
 
CME/Antworten: Hypertonie und die COVID-19-Pandemie: Was in der medizinischen Praxis zu beachten ist [CME/Answers: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]
Wuerzner G., Waeber B., 2021. Praxis, 110 (3) pp. 141-142. Peer-reviewed.
 
CME/Réponses: L’hypertension artérielle et la pandémie COVID-19: Ce qu’il faut retenir en pratique médicale [CME/Answers: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]
Wuerzner G., Waeber B., 2021. Praxis, 110 (3) pp. 1-2. Peer-reviewed.
 
Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study
Fakhouri F., Fila M., Hummel A., Ribes D., Sellier-Leclerc A. L., Ville S., Pouteil-Noble C., Coindre J. P., Le Quintrec M., Rondeau E. et al., 2021. Blood, 137 (18) pp. 2438-2449.
Hip Position Acutely Affects Oxygenation and Perfusion of Kidney Grafts as Measured by Functional Magnetic Resonance Imaging Methods-The Bent Knee Study.
Mani L.Y., Seif M., Nikles F., Tshering Vogel D.W., Diserens G., Martirosian P., Burnier M., Vogt B., Vermathen P., 2021. Frontiers in medicine, 8 p. 697055. Peer-reviewed.
How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice.
Polychronopoulou E., Wuerzner G., Burnier M., 2021. Vascular health and risk management, 17 pp. 1-11. Peer-reviewed.
 
Sex- and age-specific reference intervals for diagnostic ratios reflecting relative activity of steroidogenic enzymes and pathways in adults
Rousson V., Ackermann D., Ponte B., Pruijm M., Guessous I., d'Uscio C.H., Ehret G., Escher G., Pechère-Bertschi A., Groessl M. et al., 2021. PloS one, 16 (7) pp. e0253975. Peer-reviewed.
Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017
Travert B., Dossier A., Jamme M., Cointe A., Delmas Y., Malot S., Wynckel A., Seguin A., Presne C., Hie M. et al., 2021. Emerg Infect Dis, 27 (7) pp. 1876-1885.
Subsegmentation of the Kidney in Experimental MR Images Using Morphology-Based Regions-of-Interest or Multiple-Layer Concentric Objects.
Riazy L., Milani B., Periquito J.S., Cantow K., Niendorf T., Pruijm M., Seeliger E., Pohlmann A., 2021. pp. 549-564 dans Preclinical MRI of the Kidney, Springer.
Team-Based Care for Improving Hypertension Management: A Pragmatic Randomized Controlled Trial.
Santschi V., Wuerzner G., Pais B., Chiolero A., Schaller P., Cloutier L., Paradis G., Burnier M., 2021. Frontiers in cardiovascular medicine, 8 p. 760662. Peer-reviewed.
Prévention de la lithiase urinaire – Résultats préliminaires de la Cohorte suisse des patients souffrant de calculs rénaux et de l’étude NOSTONE [Prevention of nephrolithiasis - Preliminary results of the Swiss Kidney Stone Cohort (SKSC) and the NOSTONE trial]
Stritt K., Bosshard P., Bonny O., Roth B., 2020/12/02. Revue medicale suisse, 16 (717) pp. 2317-2320. Peer-reviewed.
 
Impact of potassium citrate on urinary risk profile, glucose and lipid metabolism of kidney stone formers in Switzerland.
Wiegand A., Fischer G., Seeger H., Fuster D., Dhayat N., Bonny O., Ernandez T., Kim M.J., Wagner C.A., Mohebbi N., 2020/12. Clinical kidney journal, 13 (6) pp. 1037-1048. Peer-reviewed.
 
In memoriam: Peter Sleight 1929-2020.
Kreutz R., Kjeldsen S.E., Burnier M., Narkiewicz K., Oparil S., Mancia G., 2020/12. Blood pressure, 29 (6) pp. 382-384. Peer-reviewed.
Oral chemolysis is an effective, non-invasive therapy for urinary stones suspected of uric acid content.
Tsaturyan A., Bokova E., Bosshard P., Bonny O., Fuster D.G., Roth B., 2020/12. Urolithiasis, 48 (6) pp. 501-507. Peer-reviewed.
 
Sodium Intake Is Associated With Renal Resistive Index in an Adult Population-Based Study.
Jaques D.A., Pruijm M., Ackermann D., Vogt B., Guessous I., Burnier M., Pechere-Bertschi A., Bochud M., Ponte B., 2020/12. Hypertension, 76 (6) pp. 1898-1905. Peer-reviewed.
 
Was it optimal to drop a diuretic as a first-line choice of drug treatment in the 2020 International Society of Hypertension Guidelines?
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2020/12. Blood pressure, 29 (6) pp. 341-343. Peer-reviewed.
Water-Soluble Vitamin Levels and Supplementation in Chronic Online Hemodiafiltration Patients.
Schwotzer N., Kanemitsu M., Kissling S., Darioli R., Benghezal M., Rezzi S., Burnier M., Pruijm M., 2020/12. Kidney international reports, 5 (12) pp. 2160-2167. Peer-reviewed.
 
Rhabdomyolyse: prise en charge médicale initiale [Rhabdomyolysis: early management]
Dall'Aglio A., Kissling S., Vollenweider P., Jaccard E., 2020/11/25. Revue medicale suisse, 16 (716) pp. 2272-2278. Peer-reviewed.
 
Clinical Profiles and Factors Associated with a Low Sodium Intake in the Population: An Analysis of the Swiss Survey on Salt.
Burnier M., Paccaud F.M., Bochud M., 2020/11/23. Nutrients, 12 (11) p. 3591. Peer-reviewed.
 
Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS) (Preprint)
Bandiera Carole, Dotta-Celio Jennifer, Locatelli Isabella, Nobre Dina, Wuerzner Grégoire, Pruijm Menno, Lamine Faiza, Burnier Michel, Zanchi Anne, Schneider Marie Paule, 2020/11/23..
Assessing the efficacy and impact of a personalised smoking cessation intervention among type 2 diabetic smokers: study protocol for an open-label randomised controlled trial (DISCGO-RCT).
Clair C., Augsburger A., Birrer P., Locatelli I., Schwarz J., Greub G., Zanchi A., Jacot-Sadowski I., Puder J.J., 2020/11/19. BMJ open, 10 (11) pp. e040117. Peer-reviewed.
 
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.
Fakhouri F., Scully M., Provôt F., Blasco M., Coppo P., Noris M., Paizis K., Kavanagh D., Pène F., Quezada S. et al., 2020/11/05. Blood, 136 (19) pp. 2103-2117. Peer-reviewed.
 
Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime.
Kreutz R., Kjeldsen S.E., Burnier M., Narkiewicz K., Oparil S., Mancia G., 2020/11. Journal of hypertension, 38 (11) pp. 2144-2145. Peer-reviewed.
 
Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties.
Fakhouri F., Le Quintrec M., Frémeaux-Bacchi V., 2020/11. Kidney international, 98 (5) pp. 1135-1148. Peer-reviewed.
Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection.
Kielstein J.T., Pontremoli R., Burnier M., 2020/10/31. Current hypertension reports, 22 (12) p. 102. Peer-reviewed.
 
Blood pressure measurements with the OptiBP smartphone app validated against reference auscultatory measurements.
Schoettker P., Degott J., Hofmann G., Proença M., Bonnier G., Lemkaddem A., Lemay M., Schorer R., Christen U., Knebel J.F. et al., 2020/10/20. Scientific reports, 10 (1) p. 17827. Peer-reviewed.
Incidence of glomerulonephritis in the western part of Switzerland over the last decade.
Nanchen G., Schutzbach K., Rotman S., Winzeler R., Ambühl P., Halfon M., Pruijm M., 2020/10/05. Swiss medical weekly, 150 pp. w20353. Peer-reviewed.
 
Is auscultation an issue when validating 24-h blood pressure monitoring devices?
Wuerzner G., Vybornova A., Wurzner-Ghajarzadeh A., Polychronopoulou E., Fallet S., Sola J., Alpert B.S., 2020/10. Blood pressure monitoring, 25 (5) pp. 301-302. Peer-reviewed.
 
The International Society of Hypertension Guidelines 2020 - a new drug treatment recommendation in the wrong direction?
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2020/10. Blood pressure, 29 (5) pp. 264-266. Peer-reviewed.
Birt-Hogg-Dubé syndrome.
Daccord C., Good J.M., Morren M.A., Bonny O., Hohl D., Lazor R., 2020/09/30. European respiratory review, 29 (157) p. 200042. Peer-reviewed.
Apport de l’échographie rénale dans l’hypertension artérielle [The role of kidney ultrasound in patients with arterial hypertension]
Dash J., Pruijm M., Ponte B., 2020/09/16. Revue medicale suisse, 16 (706) pp. 1676-1679. Peer-reviewed.
Docteur, moi je suis contre les médicaments ! []
Pechère-Bertschi A., Ponte B., Wuerzner G., 2020/09/16. Revue medicale suisse, 16 (706) p. 1671. Peer-reviewed.
Déprescription dans le contexte de l’hypertension [Deprescribing antihypertensive therapy]
Tebib N., Wuerzner G., 2020/09/16. Revue medicale suisse, 16 (706) pp. 1690-1692. Peer-reviewed.
Hypertension artérielle et cancer : une relation étroite à ne pas oublier [Hypertension and cancer : a close relationship to remember!]
Bocchi F., Jankovic J., Wuerzner G., 2020/09/16. Revue medicale suisse, 16 (706) pp. 1680-1683. Peer-reviewed.
 
Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1.
Olinger E., Hofmann P., Kidd K., Dufour I., Belge H., Schaeffer C., Kipp A., Bonny O., Deltas C., Demoulin N. et al., 2020/09. Kidney international, 98 (3) pp. 717-731. Peer-reviewed.
 
[Preliminary clinical analysis of direct renin inhibitor aliskiren in the treatment of severe coronavirus disease 2019 patients with hypertension].
Guo Y., Zeng J., Li Q., Li P., Luo F.M., Zhang W.Z., Lu Y.X., Wang Q., Zhang W., Zeng Z.P. et al., 2020/08/01. Zhonghua nei ke za zhi, 59 (8) pp. 610-617. Peer-reviewed.
A new statistical methodology overcame the defects of the Bland-Altman method.
Taffé P., Halfon P., Halfon M., 2020/08. Journal of clinical epidemiology, 124 pp. 1-7. Peer-reviewed.
Cardiovascular End Points and Mortality Are Not Closer Associated With Central Than Peripheral Pulsatile Blood Pressure Components.
Huang Q.F., Aparicio L.S., Thijs L., Wei F.F., Melgarejo J.D., Cheng Y.B., Sheng C.S., Yang W.Y., Gilis-Malinowska N., Boggia J. et al., 2020/08. Hypertension, 76 (2) pp. 350-358. Peer-reviewed.
 
Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning?
Burnier M., Kreutz R., Narkiewicz K., Kjeldsen S., Oparil S., Mancia G., 2020/08. Journal of hypertension, 38 (8) pp. 1396-1406. Peer-reviewed.
 
Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
Kreutz R., Algharably EAE, Azizi M., Dobrowolski P., Guzik T., Januszewicz A., Persu A., Prejbisz A., Riemer T.G., Wang J.G. et al., 2020/08/01. Cardiovascular research, 116 (10) pp. 1688-1699. Peer-reviewed.
 
May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension.
Beaney T., Schutte A.E., Stergiou G.S., Borghi C., Burger D., Charchar F., Cro S., Diaz A., Damasceno A., Espeche W. et al., 2020/08. Hypertension, 76 (2) pp. 333-341. Peer-reviewed.
 
Screening for hypertension at the hairdresser: a feasibility study in France and Morocco.
Boivin J.M., Risse J., Laurière E., Burnier M., 2020/08. Blood pressure, 29 (4) pp. 202-208. Peer-reviewed.
Elevated serum magnesium lowers calcification propensity in Memo1-deficient mice
Moor Matthias B., Ramakrishnan Suresh K., Legrand Finola, Bachtler Matthias, Koesters Robert, Hynes Nancy E., Pasch Andreas, Bonny Olivier, 2020/07/24. PLOS ONE, 15 (7) pp. e0236361. Peer-reviewed.
Reference values and sex differences in absolute and relative kidney size. A Swiss autopsy study.
Kalucki SA, Lardi C., Garessus J., Kfoury A., Grabherr S., Burnier M., Pruijm M., 2020/07/20. BMC nephrology, 21 (1) p. 289. Peer-reviewed.
A Multidisciplinary Approach for Improving Quality of Life and Self-Management in Diabetic Kidney Disease: A Crossover Study.
Helou N., Talhouedec D., Zumstein-Shaha M., Zanchi A., 2020/07/08. Journal of clinical medicine, 9 (7). Peer-reviewed.
Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo-Controlled Trial.
Zanchi A., Burnier M., Muller M.E., Ghajarzadeh-Wurzner A., Maillard M., Loncle N., Milani B., Dufour N., Bonny O., Pruijm M., 2020/07/07. Journal of the American Heart Association, 9 (13) pp. e016173. Peer-reviewed.
 
Antenatal corticosteroid therapy and COVID-19: Pathophysiological considerations.
Sichitiu J., Fakhouri F., Desseauve D., 2020/07. Acta obstetricia et gynecologica Scandinavica, 99 (7) p. 952. Peer-reviewed.
Collapsing glomerulopathy in a COVID-19 patient.
Kissling S., Rotman S., Gerber C., Halfon M., Lamoth F., Comte D., Lhopitallier L., Sadallah S., Fakhouri F., 2020/07. Kidney international, 98 (1) pp. 228-231. Peer-reviewed.
Qu'avons-nous appris de la pandémie de COVID-19 en Suisse latine?
Cornuz Jacques, Gabutti Luca, Guessous Idris, Reny Jean-Luc, Vollenweider Peter, Waeber Gérard, 2020/07/01. Forum Médical Suisse ‒ Swiss Medical Forum, 20 (27-30) pp. 388-389.
 
Renal handling of zinc in chronic kidney disease patients and the role of circulating zinc levels in renal function decline.
Damianaki K., Lourenco JM, Braconnier P., Ghobril JP, Devuyst O., Burnier M., Lenglet S., Augsburger M., Thomas A., Pruijm M., 2020/07/01. Nephrology, dialysis, transplantation, 35 (7) pp. 1163-1170. Peer-reviewed.
The authors reply.
Kissling S., Rotman S., Fakhouri F., 2020/07. Kidney international, 98 (1) p. 232. Peer-reviewed.
Adhésion thérapeutique et collaboration médecin-pharmacien. L’exemple du patient avec néphropathie diabétique [Medication adherence and physician-pharmacist collaboration. Focus on the patient with diabetic nephropathy]
Schneider M., Bandiera C., Dotta-Celio J., Zanchi A., 2020/06/10. Revue medicale suisse, 16 (697) pp. 1210-1213. Peer-reviewed.
Diabète post-transplantation rénale: le point de vue du diabétologue [Post-transplantation diabetes in kidney transplant: from the diabetologist point of view]
Pauchet A., Schwotzer N., Lamine F., Perrottet N., Zanchi A., Golshayan D., Wojtusciszyn A., 2020/06/10. Revue medicale suisse, 16 (697) pp. 1200-1205. Peer-reviewed.
 
Can COMBINED Magnetic Resonance Imaging Measure the Progression of Kidney Disease?
Pruijm M., 2020/06/08. Clinical journal of the American Society of Nephrology, 15 (6) pp. 747-749. Peer-reviewed.
 
Antihypertensive drugs and the risk of cancer: a critical review of available evidence and perspective.
Battistoni A., Tocci G., Coluccia R., Burnier M., Ruilope L.M., Volpe M., 2020/06. Journal of hypertension, 38 (6) pp. 1005-1015. Peer-reviewed.
 
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project.
Kreutz R., Kjeldsen S.E., Burnier M., Narkiewicz K., Oparil S., Mancia G., 2020/06. Blood pressure, 29 (3) pp. 135-136. Peer-reviewed.
Impact of kidney transplantation on sleep apnea severity: A prospective polysomnographic study.
Forni Ogna V., Ogna A., Haba-Rubio J., Nowak G., Venetz J.P., Golshayan D., Matter M., Burnier M., Pascual M., Heinzer R., 2020/06. American journal of transplantation, 20 (6) pp. 1659-1667. Peer-reviewed.
Spondyloarthritis-Associated IgA Nephropathy
Champtiaux N., Liote F., El Karoui K., Vigneau C., Miceli C., Cornec-Le Gall E., Remy P., Choukroun G., Fakhouri F., Garrouste C. et al., 2020/06. Kidney Int Rep, 5 (6) pp. 813-820.
Les bloqueurs du système rénine-angiotensine-aldostérone en temps de pandémie Covid-19 : amis ou ennemis ? [Renin-angiotensin-aldosterone blockers and Covic-19 infection : friends or enemies ?]
Pechère-Bertschi A., Ponte B., Wuerzner G., 2020/05/13. Revue medicale suisse, 16 (693) pp. 1003-1007. Peer-reviewed.
Diabète et infection à COVID-19 [Diabetes and COVID-19 infection]
Kosinski C., Zanchi A., Wojtusciszyn A., 2020/05/06. Revue medicale suisse, 16 (692) pp. 939-943. Peer-reviewed.
 
Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis.
Pisano A., Bolignano D., Mallamaci F., D'Arrigo G., Halimi J.M., Persu A., Wuerzner G., Sarafidis P., Watschinger B., Burnier M. et al., 2020/05/01. Nephrology, dialysis, transplantation, 35 (5) pp. 878-887. Peer-reviewed.
 
Nutraceuticals and blood pressure control: a European Society of Hypertension position document.
Borghi C., Tsioufis K., Agabiti-Rosei E., Burnier M., Cicero AFG, Clement D., Coca A., Desideri G., Grassi G., Lovic D. et al., 2020/05. Journal of hypertension, 38 (5) pp. 799-812. Peer-reviewed.
Prise en charge des patients avec maladies digestives et hépatiques durant la pandémie COVID-19 [Management of gastrointestinal and hepatic diseases during the COVID-19 outbreak]
Restellini S., Buyse S., Godat S., Goossens N., Maillard M.H., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 845-848. Peer-reviewed.
Vue sur le COVID-19 depuis la néphrologie [COVID-19 from the nephrologist's point of view]
Kissling S., Pruijm M., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 842-844. Peer-reviewed.
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies.
Mahfoud F., Azizi M., Ewen S., Pathak A., Ukena C., Blankestijn P.J., Böhm M., Burnier M., Chatellier G., Durand Zaleski I. et al., 2020/04/21. European heart journal, 41 (16) pp. 1588-1599. Peer-reviewed.
Uranium exposure of the Swiss population based on 24-hour urinary excretion.
Jenny-Burri J., Blanc A., Aubert R., Haldimann M., Zürcher U., Burnier M., Paccaud F., Bochud M., Dudler V., 2020/04/06. Swiss medical weekly, 150 pp. w20207. Peer-reviewed.
Ambulatory Blood Pressure in Relation to Plasma and Urinary Manganese.
Zhang ZY, Carmeli C., Ponte B., Pruijm M., Ackermann D., Ehret G., Guessous I., Petrović D., Pechère-Bertschi A., Vogt B. et al., 2020/04. Hypertension, 75 (4) pp. 1133-1139. Peer-reviewed.
 
How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers.
Burnier M., Kjeldsen S.E., Narkiewicz K., Oparil S., 2020/04. Blood pressure, 29 (2) pp. 68-69. Peer-reviewed.
Memo1 gene expression in kidney and bone is unaffected by dietary mineral load and calciotropic hormones.
Moor M.B., Bonny O., 2020/04. Physiological reports, 8 (7) pp. e14410. Peer-reviewed.
 
Parathyroid Hormone and Plasma Phosphate Are Predictors of Soluble α-Klotho Levels in Adults of European Descent
Dhayat Nasser A, Pruijm Menno, Ponte Belen, Ackermann Daniel, Leichtle Alexander Benedikt, Devuyst Olivier, Ehret Georg, Guessous Idris, Pechère-Bertschi Antoinette, Pastor Johanne et al., 2020/04/01. The Journal of Clinical Endocrinology and Metabolism, 105 (4) pp. e1135-e1143. Peer-reviewed.
Toll-Interacting Protein Regulates Immune Cell Infiltration and Promotes Colitis-Associated Cancer.
Begka C., Pattaroni C., Mooser C., Nancey S., Swiss IBD Cohort Study Group, McCoy K.D., Velin D., Maillard M.H., 2020/03/27. iScience, 23 (3) p. 100891. Peer-reviewed.
Hypophosphatémie après perfusion de fer : pouvons-nous encore l’ignorer ? [Hypophosphatemia after iron infusion : can we still ignore it ?]
Scardia S., Bonny O., Favre L., 2020/03/25. Revue medicale suisse, 16 (687) pp. 592-595. Peer-reviewed.
Prise en charge des hypertriglycéridémies et du risque de pancréatite [The management of hypertriglyceridemia and the risk of pancreatitis]
Garelli V., Pauchet A., Kissling S., Sartori C., Rodondi N., Collet T.H., 2020/03/04. Revue medicale suisse, 16 (684) pp. 451-454. Peer-reviewed.
 
Dialysis initiation improves calcification propensity.
Ponte B., Pruijm M., Pasch A., Dufey-Teso A., Martin P.Y., de Seigneux S., 2020/03/01. Nephrology, dialysis, transplantation, 35 (3) pp. 495-502. Peer-reviewed.
 
The Case | A neoplastic cause of acute kidney injury
Garandeau C., Figueres L., Renaudin K., Fakhouri F., 2020/03. Kidney Int, 97 (3) pp. 621-622.
 
The Presence of Renal IgG Deposits in Necrotizing Crescentic Glomerulonephritis Associated with ANCA Is Not Related to Worse Renal Clinical Outcomes
Dudreuilh C., Fakhouri F., Vigneau C., Augusto J. F., Machet M. C., Rabot N., Chapal M., Charpy V., Barbet C., Buchler M. et al., 2020/03. Kidney Dis (Basel), 6 (2) pp. 98-108.
Des changements en vue…
Martin P.Y., Wuerzner G., Fakhouri F., 2020/02/26. Revue medicale suisse, 16 (683) pp. 387-388. Peer-reviewed.
Dialyse péritonéale : ce que doit savoir le médecin généraliste [Peritoneal dialysis : what the general practitioner should know about peritoneal dialysis]
Schneider M., Pruijm M., Halabi G., 2020/02/26. Revue medicale suisse, 16 (683) pp. 390-394. Peer-reviewed.
Inhibiteurs de points de contrôle immunitaires et atteinte rénale : mise au point sur une pathologie émergente [Immune checkpoint inhibitors and renal toxicity : update about an emerging pathology]
Belkoniene M., Halabi G., Rotman S., Kissling S., 2020/02/26. Revue medicale suisse, 16 (683) pp. 399-403. Peer-reviewed.
Les reins : cibles du réchauffement climatique ? [The kidneys : possible victims of global warming ?]
Ngatchou N., Martin P.Y., Fakhouri F., Pruijm M., 2020/02/26. Revue medicale suisse, 16 (683) pp. 412-416. Peer-reviewed.
Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers.
Schantl A.E., Verhulst A., Neven E., Behets G.J., D'Haese P.C., Maillard M., Mordasini D., Phan O., Burnier M., Spaggiari D. et al., 2020/02/05. Nature communications, 11 (1) p. 721. Peer-reviewed.
Consensus-based technical recommendations for clinical translation of renal BOLD MRI.
Bane O., Mendichovszky I.A., Milani B., Dekkers I.A., Deux J.F., Eckerbom P., Grenier N., Hall M.E., Inoue T., Laustsen C. et al., 2020/02. Magma, 33 (1) pp. 199-215. Peer-reviewed.
 
Renal BOLD MRI in patients with chronic kidney disease: comparison of the semi-automated twelve layer concentric objects (TLCO) and manual ROI methods.
Li L.P., Milani B., Pruijm M., Kohn O., Sprague S., Hack B., Prasad P., 2020/02. Magma, 33 (1) pp. 113-120. Peer-reviewed.
 
The Health Outcomes Prevention and Evaluation 4 (HOPE 4) project: A successful community-based intervention to lower cardiovascular risk in people with hypertension.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2020/02. Blood pressure, 29 (1) pp. 1-2. Peer-reviewed.
 
Time-course of sodium transport along the nephron in nephrotic syndrome: The role of potassium.
Dizin E., Olivier V., Maire C., Komarynets O., Sassi A., Roth I., Loffing J., de Seigneux S., Maillard M., Rutkowski J.M. et al., 2020/02. FASEB journal, 34 (2) pp. 2408-2424. Peer-reviewed.
Hypertension artérielle [Hypertension: novelties 2019]
Wuerzner G., 2020/01/15. Revue medicale suisse, 16 (676-7) pp. 53-54. Peer-reviewed.
 
Quantification of Neuropeptide Y and Four of Its Metabolites in Human Plasma by Micro-UHPLC-MS/MS.
Vocat C., Dunand M., Hubers S.A., Bourdillon N., Millet G.P., Brown N.J., Wuerzner G., Grouzmann E., Eugster P.J., 2020/01/07. Analytical chemistry, 92 (1) pp. 859-866. Peer-reviewed.
HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis.
Nunes M.B., Rotman S., Duss F.R., Halfon M., 2020/01/06. BMJ case reports, 13 (1) pp. e231844. Peer-reviewed.
Brainstem Correlates of a Cold Pressor Test Measured by Ultra-High Field fMRI.
Hendriks-Balk M.C., Megdiche F., Pezzi L., Reynaud O., Da Costa S., Bueti D., Van De Ville D., Wuerzner G., 2020. Frontiers in neuroscience, 14 p. 39. Peer-reviewed.
 
C3 glomerulonephritis in a patient treated with anti-PD-1 antibody
Ville S., Kandel-Aznar C., Fremeaux-Bacchi V., Fakhouri F., 2020/01. Eur J Cancer, 125 pp. 46-48.
 
Evaluation of 24-h urine collection quality in the Swiss Kidney Stone Cohort-NCCR Kidney.CH
Legay C., Fuster D., Dhayat N. A., Seeger H., Ritter A., Ernandez T., Stoermann-Chopard C., Buchkremer F., Segerer S., Wuerzner G. et al., 2020. pp. 35S dans Abstracts of the cancelled 52nd Annual Meeting of the Swiss Society of Nephrology, Swiss Medical Weekly.
First Line CombinAtion Therapy in the Treatment of Stage II and III Hypertension (FLASH).
Spirk D., Noll S., Burnier M., Rimoldi S., Noll G., Sudano I., 2020. Frontiers in cardiovascular medicine, 7 p. 46. Peer-reviewed.
 
How reliable is renal ultrasound to measure renal length and volume in patients with chronic kidney disease compared with magnetic resonance imaging?
Braconnier P., Piskunowicz M., Vakilzadeh N., Müller M.E., Zürcher E., Burnier M., Pruijm M., 2020/01. Acta radiologica, 61 (1) pp. 117-127. Peer-reviewed.
Hypertension and Drug Adherence in the Elderly.
Burnier M., Polychronopoulou E., Wuerzner G., 2020. Frontiers in cardiovascular medicine, 7 p. 49. Peer-reviewed.
Prevalence and Description of Hyponatremia in a Swiss Tertiary Care Hospital: An Observational Retrospective Study.
Lu H., Vollenweider P., Kissling S., Marques-Vidal P., 2020. Frontiers in medicine, 7 p. 512. Peer-reviewed.
 
Renal Functional Reserve Is Related to the Nondipping Phenotype and to the Exercise Heart Rate Response in Patients with Essential Hypertension and Preserved Renal Function.
Damianaki K., Burnier M., Dimitriadis K., Tsioufis C., Petras D., 2020. Kidney & blood pressure research, 45 (5) pp. 737-747. Peer-reviewed.
Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
Burnier M., 2020. Kidney medicine, 2 (3) pp. 231-234. Peer-reviewed.
 
Short-term changes in dietary sodium intake influence sweat sodium concentration and muscle sodium content in healthy individuals.
Braconnier P., Milani B., Loncle N., Lourenco J.M., Brito W., Delacoste J., Maillard M., Stuber M., Burnier M., Pruijm M., 2020/01. Journal of hypertension, 38 (1) pp. 159-166. Peer-reviewed.
 
Monitoring Complement Activation: The New Conundrum in Thrombotic Microangiopathies.
Fakhouri F., Frémeaux-Bacchi V., 2019/12/06. Clinical journal of the American Society of Nephrology, 14 (12) pp. 1682-1683. Peer-reviewed.
 
Effect of angiotensin receptor blockers on blood pressure and renal function in patients with concomitant hypertension and chronic kidney disease: a systematic review and meta-analysis.
Burnier M., Lin S., Ruilope L., Bader G., Durg S., Brunel P., 2019/12. Blood pressure, 28 (6) pp. 358-374. Peer-reviewed.
Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome
El Karoui K., Boudhabhay I., Petitprez F., Vieira-Martins P., Fakhouri F., Zuber J., Aulagnon F., Matignon M., Rondeau E., Mesnard L. et al., 2019/12. Haematologica, 104 (12) pp. 2501-2511.
 
Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome in solid organ transplant recipients
Ville S., Ydee A., Garandeau C., Canet E., Tissot A., Cantarovich D., Fremeaux-Bacchi V., Mariani-Kurkdjian P., Provot F., Fakhouri F., 2019/12. Kidney Int, 96 (6) pp. 1423-1424.
 
Systolic blood pressure control prevents cognitive decline and slows development of white matter lesions in the brain: the SPRINT MIND study outcomes.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2019/12. Blood pressure, 28 (6) pp. 356-357. Peer-reviewed.
 
Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome
Zuber J., Frimat M., Caillard S., Kamar N., Gatault P., Petitprez F., Couzi L., Jourde-Chiche N., Chatelet V., Gaisne R. et al., 2019/12. J Am Soc Nephrol, 30 (12) pp. 2449-2463.
The intrinsic circadian clock in podocytes controls glomerular filtration rate.
Ansermet C., Centeno G., Nikolaeva S., Maillard M.P., Pradervand S., Firsov D., 2019/11/06. Scientific reports, 9 (1) p. 16089. Peer-reviewed.
 
Sex and Body Mass Index Modify the Association Between Leptin and Sodium Excretion: A Cross-sectional Study in an African Population
Schwotzer Nora, Burnier Michel, Maillard Marc, Bovet Pascal, Paccaud Fred, Bochud Murielle, Wuerzner Grégoire, 2019/10/16. American Journal of Hypertension, 32 (11) pp. 1101-1108.
 
Sex and Body Mass Index Modify the Association Between Leptin and Sodium Excretion: A Cross-sectional Study in an African Population.
Schwotzer N., Burnier M., Maillard M., Bovet P., Paccaud F., Bochud M., Wuerzner G., 2019/10/16. American journal of hypertension, 32 (11) pp. 1101-1108. Peer-reviewed.
 
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
Ruilope LM, Agarwal R, Anker SD, Bakris GL, Filippatos G, Nowack C, Kolkhof P, Joseph A, Mentenich N, Pitt B et al., 2019/10. American journal of nephrology.
 
The PARAGON-Heart failure trial - another disappointment for heart failure patients with hypertension and preserved ejection fraction.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2019/10. Blood pressure, 28 (5) pp. 276-278. Peer-reviewed.
 
Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation.
Egli-Spichtig D., Imenez Silva P.H., Glaudemans B., Gehring N., Bettoni C., Zhang MYH, Pastor-Arroyo E.M., Schönenberger D., Rajski M., Hoogewijs D. et al., 2019/10. Kidney international, 96 (4) pp. 890-905. Peer-reviewed.
 
Renal Resistive Index Is Associated With Inactive Matrix Gla (γ-Carboxyglutamate) Protein in an Adult Population-Based Study.
Jaques D.A., Pivin E., Pruijm M., Ackermann D., Guessous I., Ehret G., Wei F.F., Staessen J.A., Pechère-Bertschi A., Vermeer C. et al., 2019/09/17. Journal of the American Heart Association, 8 (18) pp. e013558. Peer-reviewed.
Adhésion thérapeutique : le maillon manquant du contrôle tensionnel [Medication adherence : the weakest link in blood pressure control]
Gonzalez A., Pechère-Bertschi A., Burnier M., Schneider M., 2019/09/11. Revue medicale suisse, 15 (662) pp. 1608-1613. Peer-reviewed.
Hypertension artérielle et syndrome des apnées obstructives du sommeil : état des connaissances [Arterial hypertension and obstructive sleep apnea syndrome: state of knowledge]
Salmina D., Ogna A., Wuerzner G., Heinzer R., Forni Ogna V., 2019/09/11. Revue medicale suisse, 15 (662) pp. 1620-1624. Peer-reviewed.
Hypertension de la personne âgée : les nouvelles recommandationsont-elles changé la prise en charge ? [Hypertension in the elderly : have new guidelines changed the management ?]
Polychronopoulou E., Burnier M., Wuerzner G., 2019/09/11. Revue medicale suisse, 15 (662) pp. 1597-1602. Peer-reviewed.
Quand le patient devient une cible, comment faire ?
Ponte B., Pechère-Bertschi A., Wuerzner G., 2019/09/11. Revue medicale suisse, 15 (662) p. 1595. Peer-reviewed.
 
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.
Martins F., Sofiya L., Sykiotis G.P., Lamine F., Maillard M., Fraga M., Shabafrouz K., Ribi C., Cairoli A., Guex-Crosier Y. et al., 2019/09. Nature reviews. Clinical oncology, 16 (9) pp. 563-580. Peer-reviewed.
 
Estimated 24-h urinary sodium and sodium-to-potassium ratio are predictors of kidney function decline in a population-based study.
Deriaz D., Guessous I., Vollenweider P., Devuyst O., Burnier M., Bochud M., Ponte B., 2019/09. Journal of hypertension, 37 (9) pp. 1853-1860. Peer-reviewed.
 
Is blood pressure measured correctly in dialysis centres? Physicians' and patients' views
Pappaccogli Marco, Labriola Laura, Van der Niepen Patricia, Pruijm Menno, Vogt Liffert, Halimi Jean-Michel, Ferro Charles J, Halabi Georges, Phan Olivier, Bullani Roberto et al., 2019/09/01. Nephrology Dialysis Transplantation, 34 (9) pp. 1612-1615.
 
Is blood pressure measured correctly in dialysis centres? Physicians' and patients' views.
Pappaccogli M., Labriola L., Van der Niepen P., Pruijm M., Vogt L., Halimi J.M., Ferro C.J., Halabi G., Phan O., Bullani R. et al., 2019/09/01. Nephrology, dialysis, transplantation, 34 (9) pp. 1612-1615. Peer-reviewed.
Syphilis and parvovirus B19 co-infection imitating a lupus nephropathy: A case report.
Jaunin E., Kissling S., Rotman S., Waeber G., Halfon M., 2019/09. Medicine, 98 (36) pp. e17040. Peer-reviewed.
Redefining diuretics use in hypertension: why select a thiazide-like diuretic?
Burnier M., Bakris G., Williams B., 2019/08. Journal of hypertension, 37 (8) pp. 1574-1586. Peer-reviewed.
 
The PARAGON Heart Failure trial - ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2019/08. Blood pressure, 28 (4) pp. 215-216. Peer-reviewed.
The serine-threonine kinase PIM3 is an aldosterone-regulated protein in the distal nephron.
Spirli A., Cheval L., Debonneville A., Penton D., Ronzaud C., Maillard M., Doucet A., Loffing J., Staub O., 2019/08. Physiological reports, 7 (15) pp. e14177. Peer-reviewed.
 
Cardiovascular disease and uric acid: is the not-so-innocent bystander becoming a true culprit and does the US black box warning for febuxostat indicate that not all uric acid lowering is beneficial?
Messerli F.H., Burnier M., 2019/06/07. European heart journal, 40 (22) pp. 1787-1789. Peer-reviewed.
Dosage de la cystatine C dans l'évaluation de la fonction rénale
Bornet Marc-Antoine, Beaud Floriane, Bardy Daniel, Boulat Olivier, Kissling Sébastien, 2019/06/05. Forum Médical Suisse ‒ Swiss Medical Forum. Peer-reviewed.
 
A preliminary survey of practice patterns across several European kidney stone centers and a call for action in developing shared practice.
Ferraro P.M., Arrabal-Polo M.Á., Capasso G., Croppi E., Cupisti A., Ernandez T., Fuster D.G., Galan J.A., Grases F., Hoorn E.J. et al., 2019/06. Urolithiasis, 47 (3) pp. 219-224. Peer-reviewed.
 
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors
Le Clech A., Simon-Tillaux N., Provot F., Delmas Y., Vieira-Martins P., Limou S., Halimi J. M., Le Quintrec M., Lebourg L., Grange S. et al., 2019/06. Kidney Int, 95 (6) pp. 1443-1452.
 
Exploring a new method for quantitative sodium MRI in the human upper leg with a surface coil and symmetrically arranged reference phantoms.
Milani B., Delacoste J., Burnier M., Pruijm M., 2019/06. Quantitative imaging in medicine and surgery, 9 (6) pp. 985-999. Peer-reviewed.
Health status and quality of life in patients with diabetes in Switzerland.
Arditi C., Zanchi A., Peytremann-Bridevaux I., 2019/06. Primary care diabetes, 13 (3) pp. 233-241. Peer-reviewed.
 
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2019/06. Blood pressure, 28 (3) pp. 144-145. Peer-reviewed.
 
Urinary Sex Steroid and Glucocorticoid Hormones Are Associated With Muscle Mass and Strength in Healthy Adults.
Bochud M., Ponte B., Pruijm M., Ackermann D., Guessous I., Ehret G., Escher G., Groessl M., Estoppey Younes S., d'Uscio C.H. et al., 2019/06/01. The Journal of clinical endocrinology and metabolism, 104 (6) pp. 2195-2215. Peer-reviewed.
 
Défis dans la prise en charge du diabète en hémodialyse chronique [Challenges in managing diabetes in chronic hemodialysis]
Lamine F., Chtioui H., Schwotzer N., Pruijm M., Nobre D., Phan O., Ammor N., Andrey M., Grangier-Bernard P., Zanchi A., 2019/05/29. Revue medicale suisse, 15 (653) pp. 1132-1139. Peer-reviewed.
Use of day and night urinary iodine excretion to estimate the prevalence of inadequate iodine intakes via the estimated average requirement cut-point method.
Stalder E., Haldimann M., Blanc A., Dudler V., Ponte B., Pruijm M., Ackermann D., Bochud M., 2019/05/20. Swiss medical weekly, 149 pp. w20090. Peer-reviewed.
 
A model of uric acid transport in the rat proximal tubule.
Edwards A., Auberson M., Ramakrishnan S.K., Bonny O., 2019/05/01. American journal of physiology. Renal physiology, 316 (5) pp. F934-F947. Peer-reviewed.
 
Associations of ‘Relative corticosterone deficiency' with genetic variation in CYP17A1 and metabolic syndrome features
Mackenzie Scott D, Crawford Andrew A, Ackermann Daniel, Schraut Katharina E, Hayward Caroline, Bolton Jennifer L, Saunders Christopher, Al-Dujaili Emad, Dick Bernhard, Escher Geneviève et al., 2019/05..
May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension.
Beaney T, Burrell LM, Castillo RR, Charchar FJ, Cro S, Damasceno A, Kruger R, Nilsson PM, Prabhakaran D, Ramirez AJ et al., 2019/05. European heart journal.
 
Uric acid and hypertension: a focused review and practical recommendations.
De Becker B., Borghi C., Burnier M., van de Borne P., 2019/05. Journal of hypertension, 37 (5) pp. 878-883. Peer-reviewed.
Néphropathie diabétique - Prise en charge multidisciplinaire du diabète : recommandations pour la pratique clinique
Arditi C., Zanchi A., Hagon-Traub I., Burnand B., 2019/04/17. Revue medicale suisse, 15 (647) p. 841. Peer-reviewed.
 
Acute hyperglycemia increases renal tissue oxygenation as measured by BOLD-MRI in healthy overweight volunteers.
Vakilzadeh N., Zanchi A., Milani B., Ledoux J.B., Braconnier P., Burnier M., Pruijm M., 2019/04. Diabetes research and clinical practice, 150 pp. 138-143. Peer-reviewed.
 
Dampening of CD8+ T Cell Response by B Cell Depletion Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Neel A., Bucchia M., Neel M., Tilly G., Caristan A., Yap M., Rimbert M., Bruneau S., Cadoux M., Agard C. et al., 2019/04. Arthritis Rheumatol, 71 (4) pp. 641-650.
Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study
Menne J., Delmas Y., Fakhouri F., Kincaid J. F., Licht C., Minetti E. E., Mix C., Provot F., Rondeau E., Sheerin N. S. et al., 2019/04. Clin Kidney J, 12 (2) pp. 196-205.
 
Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension?
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2019/04. Blood pressure, 28 (2) pp. 75-76. Peer-reviewed.
 
Adherence in Hypertension.
Burnier M., Egan B.M., 2019/03/29. Circulation research, 124 (7) pp. 1124-1140. Peer-reviewed.
 
C3 glomerulopathy - understanding a rare complement-driven renal disease
Smith R. J. H., Appel G. B., Blom A. M., Cook H. T., D'Agati V. D., Fakhouri F., Fremeaux-Bacchi V., Jozsi M., Kavanagh D., Lambris J. D. et al., 2019/03. Nat Rev Nephrol, 15 (3) pp. 129-143.
Accès vasculaire du patient hémodialysé - Que doit savoir le spécialiste en médecine interne générale ? [The vascular access of hemodialysis patients - What should the primary care physician know about ?]
Pivin E., Cunha Moreira Da Silva F.A., Calanca L., Deglise S., Pruijm M., 2019/02/20. Revue medicale suisse, 15 (639) pp. 439-443. Peer-reviewed.
La peau comme « troisième rein » [The skin as « third kidney »]
Wurzner-Ghajarzadeh A., Braconnier P., Burnier M., Pruijm M., 2019/02/20. Revue medicale suisse, 15 (639) pp. 418-421. Peer-reviewed.
Michel Burnier : une carrière dédiée à la néphrologie et l’hypertension.
Martin P.Y., Pruijm M., 2019/02/20. Revue medicale suisse, 15 (639) pp. 415-416. Peer-reviewed.
 
Prescription des solutions hydroélectrolytiques à l’hôpital : du besoin jusqu’à l’excès [Prescribing intravenous fluids in hospitalized patients : from need to harm]
Erard Y., Kissling S., 2019/02/20. Revue medicale suisse, 15 (639) pp. 427-431. Peer-reviewed.
 
Endothelium structure and function in kidney health and disease
Jourde-Chiche N., Fakhouri F., Dou L., Bellien J., Burtey S., Frimat M., Jarrot P. A., Kaplanski G., Le Quintrec M., Pernin V. et al., 2019/02. Nat Rev Nephrol, 15 (2) pp. 87-108.
 
Liberalizing the diet of patients undergoing dialysis: are we ready?
Avesani C.M., Teta D., Carrero J.J., 2019/02/01. Nephrology, dialysis, transplantation, 34 (2) pp. 180-183. Peer-reviewed.
 
New data on antihypertensive drugs and risk of cancer: should we worry?
Burnier M., Narkiewicz K., Kjeldsen S.E., Oparil S., 2019/02. Blood pressure, 28 (1) pp. 1-3. Peer-reviewed.
 
Should we eat more potassium to better control blood pressure in hypertension?
Burnier M., 2019/02/01. Nephrology, dialysis, transplantation, 34 (2) pp. 184-193. Peer-reviewed.
 
Hypertension artérielle [Arterial hypertension : novelties in 2018]
Burnier M., Wuerzner G., 2019/01/09. Revue medicale suisse, 15 (N° 632-633) pp. 57-61. Peer-reviewed.
Commentary: Statistical Adhockeries Are No Criteria for Legal Decisions-The Case of the Expert Medical Report on the Assessment of Urine Specimens Collected Among Athletes Having Participated to the Vancouver and Sochi Winter Olympic Games.
Burnier M., 2019. Frontiers in sociology, 4 p. 85. Peer-reviewed.
 
Etiology and Outcomes of Thrombotic Microangiopathies
Bayer G., von Tokarski F., Thoreau B., Bauvois A., Barbet C., Cloarec S., Merieau E., Lachot S., Garot D., Bernard L. et al., 2019. Clin J Am Soc Nephrol, 14 (4) pp. 557-566.
 
Image acquisition for intravoxel incoherent motion imaging of kidneys should be triggered at the instant of maximum blood velocity: evidence obtained with simulations and in vivo experiments.
Milani B., Ledoux J.B., Rotzinger D.C., Kanemitsu M., Vallée J.P., Burnier M., Pruijm M., 2019/01. Magnetic resonance in medicine, 81 (1) pp. 583-593. Peer-reviewed.
 
Lack of Renal Tubular Glucocorticoid Receptor Decreases the Thiazide-Sensitive Na<sup>+</sup>/Cl<sup>-</sup> Cotransporter NCC and Transiently Affects Sodium Handling.
Canonica J., Frateschi S., Boscardin E., Ebering A., Sergi C., Jäger Y., Peyrollaz T., Mérillat A.M., Maillard M., Klusonova P. et al., 2019. Frontiers in physiology, 10 p. 989. Peer-reviewed.
New Insights on the Role of Sodium in the Physiological Regulation of Blood Pressure and Development of Hypertension.
Polychronopoulou E., Braconnier P., Burnier M., 2019. Frontiers in cardiovascular medicine, 6 p. 136. Peer-reviewed.
Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study
Menne J., Delmas Y., Fakhouri F., Licht C., Lommele A., Minetti E. E., Provot F., Rondeau E., Sheerin N. S., Wang J. et al., 2019. BMC Nephrol, 20 (1) p. 125.
Reference intervals for the urinary steroid metabolome: The impact of sex, age, day and night time on human adult steroidogenesis.
Ackermann D., Groessl M., Pruijm M., Ponte B., Escher G., d'Uscio C.H., Guessous I., Ehret G., Pechère-Bertschi A., Martin P.Y. et al., 2019. PloS one, 14 (3) pp. e0214549. Peer-reviewed.
Sodium intake and blood pressure in children with clinical conditions: A systematic review with meta-analysis.
Rios-Leyvraz M., Bloetzer C., Chatelan A., Bochud M., Burnier M., Santschi V., Paradis G., Tabin R., Bovet P., Chiolero A., 2019/01. Journal of clinical hypertension, 21 (1) pp. 118-126. Peer-reviewed.
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
Dhayat N.A., Faller N., Bonny O., Mohebbi N., Ritter A., Pellegrini L., Bedino G., Schönholzer C., Venzin R.M., Hüsler C. et al., 2018/12/10. BMC nephrology, 19 (1) p. 349. Peer-reviewed.
 
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.
Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., Clement D., Coca A., De Simone G., Dominiczak A. et al., 2018/12. Blood pressure, 27 (6) pp. 314-340. Peer-reviewed.
 
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/12. Blood pressure, 27 (6) p. 313. Peer-reviewed.
 
In Reply to 'Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy'
Le Quintrec M., Fremeaux-Bacchi V., Fakhouri F., 2018/12. Am J Kidney Dis, 72 (6) pp. 906-907.
SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney.
Auberson M., Stadelmann S., Stoudmann C., Seuwen K., Koesters R., Thorens B., Bonny O., 2018/12. Pflugers Archiv, 470 (12) pp. 1739-1751. Peer-reviewed.
 
Conduite à tenir face au syndrome de sécrétion inappropriée d’hormone antidiurétique (SIADH) [Approach to the syndrome of inappropriate antidiuretic hormone secretion (SIADH)]
Martin J., Burnier M., Lu H., 2018/11/21. Revue medicale suisse, 14 (628) pp. 2116-2120. Peer-reviewed.
 
L’acidose métabolique aux soins intensifs : considérations théoriques et aspects pratiques [Metabolic acidosis in critical care : theoretical and practical aspects]
Gross A., Kissling S., Schneider A., 2018/11/07. Revue medicale suisse, 14 (626) pp. 2025-2029. Peer-reviewed.
 
Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism.
Carrero J.J., Thomas F., Nagy K., Arogundade F., Avesani C.M., Chan M., Chmielewski M., Cordeiro A.C., Espinosa-Cuevas A., Fiaccadori E. et al., 2018/11. Journal of renal nutrition, 28 (6) pp. 380-392. Peer-reviewed.
 
Uromodulin and Nephron Mass.
Pivin E., Ponte B., de Seigneux S., Ackermann D., Guessous I., Ehret G., Pechère-Bertschi A., Olinger E., Mohaupt M., Vogt B. et al., 2018/10/08. Clinical journal of the American Society of Nephrology, 13 (10) pp. 1556-1557. Peer-reviewed.
 
A model of calcium transport and regulation in the proximal tubule.
Edwards A., Bonny O., 2018/10/01. American journal of physiology. Renal physiology, 315 (4) pp. F942-F953. Peer-reviewed.
Circadian rhythms and the kidney.
Firsov D., Bonny O., 2018/10. Nature reviews. Nephrology, 14 (10) pp. 626-635. Peer-reviewed.
 
Impact of salt reduction in meals consumed during hemodialysis sessions on interdialytic weight gain and hemodynamic stability.
Colson A., Brinkley A., Braconnier P., Ammor N., Burnier M., Pruijm M., 2018/10. Hemodialysis international. International Symposium on Home Hemodialysis, 22 (4) pp. 501-506. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University